Connect with us

Business

COVID-19 vaccine: FDA grants Pfizer emergency use for children aged 12 to 15 – CBS News

An analysis that included 1,005 vaccine participants in this age group found the vaccine was 100% effective in preventing COVID-19.

Published

on

Article feature image

The Food and Drug Administration has expanded the emergency use authorization for the Pfizer COVID-19 vaccine to children aged 12 to 15, meaning access for millions more adolescents. The Pfizer vaccine is so far still the only one approved for use in 16-to-18 year olds. 
The emergency use authorization had been expected. An analysis that included 1,005 vaccine participants in this age group found the vaccine was 100% effective in preventing COVID-19. 
In a press conference Monday night, FDA acting…

Click here to view the original article.